| Study ID |
Comparison |
Study population |
% carriers (N) |
| Blakebrough 1980 |
Rifampin versus sulphadimidine |
Household contacts |
17 (479) |
| Borgono 1981 |
Rifampin versus placebo |
Children |
12 (2132) |
| Cuevas 1995 |
Rifampin versus ciprofloxacin versus ceftriaxone |
Household contacts |
11 (1875) |
| Deal 1969b |
Rifampin versus placebo |
Students |
14.4 (270) |
| Deal 1969a |
Cephalexin versus placebo |
Students |
9.4 (352) |
| Devine 1970b |
Rifampin versus placebo |
Military recruits |
64 (103) |
| Devine 1971a |
Minocycline versus placebo |
Military recruits |
72 (121) |
| Devine 1970a |
Coumermycin A1 versus placebo |
Military recruits |
55 (129) |
| Dworzack 1988 |
Ciprofloxacin versus placebo |
Volunteers |
6.7 (620) |
| Girgis 1998 |
Azithromycin versus placebo |
Students |
24 (500) |
| Guttler 1971 |
Rifampin versus minocycline |
Military recruits |
21 (587) |
| Kaiser 1974 |
Rifampin versus placebo |
Household contacts |
35 (54) |
| Kaya 1997 |
Ciprofloxacin versus rifampin |
Hospital staff |
18 (300) |
| Munford 1974 |
Rifampin versus minocycline versus minocycline/rifampin versus sulphadiazine |
Household contacts |
25 (1187) |
| Pugsley 1984 |
Sch 29,482 versus placebo |
Volunteers |
25 (555) |
| Pugsley 1987 |
Ciprofloxacin versus placebo |
Students |
7 (461) |
| Renkonen 1987 |
Ciprofloxacin versus placebo |
Military recruits |
38.6 (552) |
| Schwartz 1988 |
Rifampin versus ceftriaxone |
Household contacts |
33 (347) |
| Simmons 2000 |
Rifampin versus ceftriaxone |
Household contacts |
21 (864) |
